Randomized Controlled Trials

Randomized Controlled Trials (RCTs) are a rigorous scientific research design, considered the gold standard for evaluating the effectiveness of an intervention. Its core principle is the random allocation of subjects to an experimental group (receiving the intervention) or a control group. This process minimizes selection bias, ensuring comparability between groups. Originating from clinical medicine, its guidelines are detailed in the ICH E6 Good Clinical Practice. In risk management, RCTs provide the highest level of evidence for validating the effectiveness of risk treatments. For the automotive industry, this allows for objectively proving, with quantitative data, that a cybersecurity control (e.g., a new firewall) effectively reduces attack success rates, fulfilling the validation requirements of ISO 21434 Clause 11.

In automotive cybersecurity, an enterprise can apply RCTs through these steps: 1. Define Hypothesis & Metrics: Formulate a clear hypothesis, e.g., 'IDS A increases detection of CAN bus spoofing to 99.5% compared to IDS B's 95%.' Define KPIs like detection rate and false positive rate. 2. Randomize & Set Up: Use a fleet of identical vehicles or HIL testbeds and randomly assign them to Group A (IDS A), Group B (IDS B), or a control group (no IDS). Ensure all environments are identical. 3. Execute & Collect Data: Deploy standardized attack scripts, based on TARA (ISO 21434), against all units. Automatically collect log data on threat detection. A European OEM used this method to validate a new OTA update mechanism, proving it increased the average time-to-crack by 400%, thus reducing the risk level from 'High' to 'Low' and passing audits.

Taiwan's automotive enterprises face three main challenges in adopting RCTs: 1. High Cost and Complexity: Building large-scale, isolated vehicle test environments is expensive and requires interdisciplinary expertise. Solution: Start with virtualized platforms (SIL/HIL) to reduce costs and partner with expert firms like Winners Consulting for complex designs. 2. Lack of Standardized Attack Scenarios: Unlike defined diseases in medicine, cyber threats evolve rapidly. Solution: Develop a proprietary attack library based on frameworks like MITRE ATT&CK® for ICS and Auto-ISAC intelligence, keeping it updated per ISO 21434. 3. Safety and Ethical Concerns: Testing on near-production vehicles poses safety risks (ISO 26262). Solution: Establish an internal Cybersecurity Research Ethics Board to review all test protocols, conduct tests in isolated environments, and have robust emergency plans.

Winners Consulting specializes in randomized controlled trials for Taiwan enterprises, delivering compliant management systems within 90 days. Free consultation: https://winners.com.tw/contact